https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00254-X/fulltext
0
0
12/12/22 at 11:52am
Organization
The Lancet
Authors
Although seroprevalence is declining, a significant proportion of Europe's population
is infected with HSV-2. HSV-2 accounts for approximately one-fifth of GUD cases and
two-thirds of genital herpes cases. Findings support the need to invest in HSV-2 vaccine
…
Create an account
or login to join the discussion